Literature DB >> 26576835

Hypomethylating Agents as Bridging Therapy before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chronic Myelomonocytic Leukemia?

Marie Robin1, Pierre Fenaux2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26576835     DOI： 10.1016/j.bbmt.2015.11.004

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  3 in total

1.  A prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantation.

Authors:  Nico Gagelmann; Anita Badbaran; Dietrich W Beelen; Rachel B Salit; Friedrich Stölzel; Christina Rautenberg; Heiko Becker; Aleksandar Radujkovic; Victoria Panagiota; Rashit Bogdanov; Maximilian Christopeit; Yong Park; Olivier Nibourel; Thomas Luft; Michael Koldehoff; Maarten Corsten; Michael Heuser; Jürgen Finke; Guido Kobbe; Uwe Platzbecker; Marie Robin; Bart L Scott; Nicolaus Kröger
Journal:  Blood Adv       Date:  2021-03-23

2.  Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNet.

Authors:  Raphael Itzykson; Pierre Fenaux; David Bowen; Nicholas C P Cross; Jorge Cortes; Theo De Witte; Ulrich Germing; Francesco Onida; Eric Padron; Uwe Platzbecker; Valeria Santini; Guillermo F Sanz; Eric Solary; Arjan Van de Loosdrecht; Luca Malcovati
Journal:  Hemasphere       Date:  2018-11-29

Review 3.  Approaching First-Line Treatment in Patients With Advanced CMML: Hypomethylating Agents or Cytotoxic Treatment?

Authors:  Konstantinos Liapis; Ioannis Kotsianidis
Journal:  Front Oncol       Date:  2021-12-13       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.